These findings indicate that TFF1 knockdown not only suppresses the malignant phenotype of lung cancer cells in vitro but also significantly inhibits tumor growth and progression in vivo, highlighting its potential therapeutic value. The gene discussed is TFF1; the disease is neoplasm.